Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly
A Korycka-Wołowiec, D Wołowiec… - Expert Opinion on Drug …, 2015 - Taylor & Francis
Introduction: Small molecule inhibitors are currently in various stages of preclinical and
clinical trials and are expected to revolutionize the treatment of many neoplastic diseases …
clinical trials and are expected to revolutionize the treatment of many neoplastic diseases …
Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly.
A Korycka-Wołowiec, D Wołowiec… - Expert Opinion on Drug …, 2015 - europepmc.org
This article reviews the chemical structure, mechanisms of action, pharmacodynamic and
pharmacokinetic properties, as well as clinical applications of small molecules in the …
pharmacokinetic properties, as well as clinical applications of small molecules in the …
Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly
A Korycka-Wołowiec, D Wołowiec… - Expert opinion on …, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction Small molecule inhibitors are currently in various stages of preclinical and
clinical trials and are expected to revolutionize the treatment of many neoplastic diseases …
clinical trials and are expected to revolutionize the treatment of many neoplastic diseases …